BioSpace News Archive

Business

Prevail and Lonza Deepen Partnership with New Collaboration

The two companies will partner on the process development, analytical development and large-scale manufacturing for late-stage clinical and commercial supply.

October 8, 2019
·
2 min read
·
Alex Keown
Business

Sensyne Health Maiden Full Year Results

Sensyne Health plc, the British Clinical AI technology company, announces its audited full year results for the 12 months ended 30 April 2019.

October 8, 2019
·
3 min read
Policy

Acorda Appeal Snubbed by Supreme Court for MS Drug Patents

Acorda Therapeutics’ attempt to preserve its patent protection for multiple sclerosis drug Ampyra hit the proverbial wall Monday when the U.S. Supreme Court refused to hear the company’s appeal of a lower court ruling.

October 8, 2019
·
2 min read
·
Alex Keown
Pharm Country

Castor Announces International Expansion to Meet Growing Demand for AI-Powered Clinical Data Platform

Amsterdam, The Netherlands and Hoboken, New Jersey, USA, October 7, 2019: Castor, a health-tech company that helps medical researchers maximize the value of research data, announces its international business expansion.

October 8, 2019
·
3 min read
Business

Sareum: Notice of FY 2019 Results

Sareum Holdings plc, the specialised small molecule drug development business, will announce its results for the full year ended 30 June 2019 on Tuesday 15 October.

October 8, 2019
·
2 min read
Deals

MiroBio launches with £27m ($34m) Series A from leading life sciences investors

Oxford start-up developing novel therapeutics based on deep expertise in immune cell regulation

October 8, 2019
·
3 min read
Drug Development

Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole’s Microbiome Preservation to Improved Clinical Outcomes for Patients with C. difficile Infection

Summit Therapeutics plc announced the presentation of new data that explain the link between two key findings in the Company’s Phase 2 clinical trial of ridinilazole for C. difficile infection

October 8, 2019
·
7 min read
Business

Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx

Akcea and Ionis to earn $250 million license fee

October 8, 2019
·
9 min read
Deals

Innovate Biopharmaceuticals to Merge with RDD Pharma Creating New Gastroenterology Company Focused on Specialty, Rare and Orphan Diseases

Innovate Biopharmaceuticals, Inc. and RDD Pharma, Ltd announced that the two companies entered into a definitive merger agreement pursuant to which Innovate agreed to acquire all of the outstanding capital stock of privately-held RDD in exchange for a combination of common and preferred shares.

October 8, 2019
·
10 min read
Khiron to Participate at BMO & TMX Hemp & Medical Cannabis Conference in London, UK

BMO & TMX Hemp & Medical Cannabis Conference, taking place in in London, UK on October 16, 2019.

October 8, 2019
·
3 min read